We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ZLD market cap is 6.18M. The company's latest EPS is AUD -3.8184 and P/E is -0.17.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.03M | 2.09M | 2.88M | 1.69M | 1.02M |
| Operating Income | -6.91M | -8.33M | -10.79M | -7.33M | -35.77M |
| Net Income | -7.02M | -8.55M | -11.95M | -5.57M | -36.57M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 35.79M | 39.37M | 37.7M | 33.89M | 5.18M |
| Total Liabilities | 1.24M | 1.54M | 2.01M | 2.18M | 9.36M |
| Total Equity | 34.55M | 37.83M | 35.69M | 31.71M | -4.17M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -6.94M | -8.62M | -9.43M | -7.25M | -4.39M |
| Investing | 1.11M | 1.38M | -208k | 2.83M | 920k |
| Financing | 4.5M | 10.53M | 7.1M | 1.77M | 3.92M |
| Market Cap | 6.18M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 6.04 |
| Price to Cash Ratio | 10.46 |
| Price to Book Ratio | -1.47 |
| Dividend Yield | - |
| Shares Outstanding | 9.58M |
| Average Volume (1 week) | 3.31k |
| Average Volume (1 Month) | 4.58k |
| 52 Week Change | -39.72% |
| 52 Week High | 1.1025 |
| 52 Week Low | 0.28 |
| Spread (Intraday) | 0.05 (7.14%) |
| Company Name | Zelira Therapeutics Limited |
| Address |
level 3 perth, western australia 6000 |
| Website | https://www.zeldatherapeutics.com |
| Industry | gold ores (1041) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
